Pneumonia in acute ischemic stroke patients requiring invasive ventilation: Impact on short and long-term outcomes.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
09 2019
Historique:
received: 12 04 2019
revised: 06 06 2019
accepted: 20 06 2019
pubmed: 27 6 2019
medline: 11 7 2020
entrez: 26 6 2019
Statut: ppublish

Résumé

To describe the epidemiology and prognostic impact of pneumonia in acute ischemic stroke patients requiring invasive mechanical ventilation. Retrospective analysis from a prospective multicenter cohort study of critically ill patients with acute ischemic stroke requiring invasive mechanical ventilation at admission. Impact of pneumonia was investigated using Cox regression for 1-year mortality, and competing risk survival models for ICU mortality censored at 30-days. We included 195 patients. Stroke was supratentorial in 62% and 64% of patients had a Glasgow coma scale score <8 on admission. Mortality at day-30 and 1 year were 56%, and 70%, respectively. Post-stroke pneumonia was identified in 78 (40%) patients, of which 46/78 (59%) episodes were present at ICU admission. Post-stroke pneumonia was associated with an increase in 1-year mortality (adjusted HR 1.49, 95%CI [1.01-2.20]). Post-stroke pneumonia was not associated with ICU mortality but was associated with a 1.6-fold increase in ICU length of stay (CSHR 0.62 [0.39-0.99], p = 0.06). In ischemic stroke patients requiring invasive ventilation, pneumonia occurred in 40% of cases and was associated with a 49% increase in 1-year mortality. Post-stroke pneumonia did not impact day-30 mortality but increased ICU length of stay.

Identifiants

pubmed: 31238051
pii: S0163-4453(19)30193-8
doi: 10.1016/j.jinf.2019.06.012
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-227

Informations de copyright

Copyright © 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Auteurs

Etienne de Montmollin (E)

UMR 1137, IAME, Paris Diderot University, Sorbonne Paris Cité, 16 rue Henri Huchard, 75018 Paris, France; Medical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat-Claude Bernard Hospital, 46 rue Henri Huchard, 75018 Paris, France. Electronic address: etienne.demontmollin@aphp.fr.

Stephane Ruckly (S)

UMR 1137, IAME, Paris Diderot University, Sorbonne Paris Cité, 16 rue Henri Huchard, 75018 Paris, France.

Carole Schwebel (C)

Medical Intensive Care Unit, Grenoble University Hospital, Grenoble 1 University, Avenue Maquis du Grésivaudan, 38700 La Tronche, France.

Francois Philippart (F)

Intensive Care Unit, Saint Joseph Hospital Network, 185 Rue Raymond Losserand, 75014 Paris, France; UMR 9891, CNRS-CEA-Paris Saclay university, 1 Avenue De La Terrasse, 91190 Gif-sur-Yvette, France.

Christophe Adrie (C)

Physiology department, AP-HP, Cochin Hospital, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France.

Eric Mariotte (E)

Medical Intensive Care Unit, AP-HP, Saint-Louis Hospital, 1 Avenue Claude Vellefaux, 75010 Paris, France.

Guillaume Marcotte (G)

Surgical Intensive Care Unit, Lyon University Hospital, 5 Place d'Arsonval, 69003 Lyon, France.

Yves Cohen (Y)

Intensive Care Unit, AP-HP, Avicenne Hospital, Paris 13 University, 125 Rue de Stalingrad, 93000 Bobigny, France.

Benjamin Sztrymf (B)

Intensive Care Unit, AP-HP, Antoine Béclère Hospital, 157 Rue de la Porte de Trivaux, 92140 Clamart, France.

Daniel da Silva (D)

Intensive Care Unit, Delafontaine Hospital, 2 Rue du Dr Delafontaine, 93200 Saint-Denis, France.

Fabrice Bruneel (F)

Intensive Care Unit, André Mignot Hospital, 177 Rue de Versailles, 78150 Le Chesnay, France.

Marc Gainnier (M)

Intensive Care Unit, AP-HM, La Timone Hospital, Aix-Marseille University, 278 Rue Saint-Pierre, 13005 Marseille, France.

Maité Garrouste-Orgeas (M)

UMR 1137, IAME, Paris Diderot University, Sorbonne Paris Cité, 16 rue Henri Huchard, 75018 Paris, France; Medical Unit, French British Hospital, 4 rue Kléber, 92300 Levallois-Perret, France.

Romain Sonneville (R)

Medical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat-Claude Bernard Hospital, 46 rue Henri Huchard, 75018 Paris, France; UMR 1148, LVTS, Paris Diderot University, Sorbonne Paris Cité, 46 rue Henri Huchard, 75018 Paris, France.

Jean-François Timsit (JF)

UMR 1137, IAME, Paris Diderot University, Sorbonne Paris Cité, 16 rue Henri Huchard, 75018 Paris, France; Medical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat-Claude Bernard Hospital, 46 rue Henri Huchard, 75018 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH